View graph of relations
  1. 2018
  2. Published
    Westwood, S., Baird, A. L., Hye, A., Ashton, N. J., Nevado-Holgado, A. J., Anand, S. N., ... Lovestone, S. (2018). Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result. Frontiers in Aging Neuroscience, 10, [409]. https://doi.org/10.3389/fnagi.2018.00409
  3. Published
    Alzheimer's Dis Neuroimaging, & Amsterdam Dementia Cohort (2018). Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline. Brain, 141, 3443-3456. https://doi.org/10.1093/brain/awy264
  4. Published
    Legdeur, N., Badissi, M., Carter, S. F., de Crom, S., van de Kreeke, A., Vreeswijk, R., ... Visser, P. J. (2018). Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+study. BMC Geriatrics, 18, [289]. https://doi.org/10.1186/s12877-018-0984-z
  5. Published
    Bergeron, D., Gorno-Tempini, M. L., Rabinovici, G. D., Santos-Santos, M. A., Seeley, W., Miller, B. L., ... Ossenkoppele, R. (2018). Prevalence of amyloid-beta pathology in distinct variants of primary progressive aphasia. Annals of Neurology, 84(5), 729-740. https://doi.org/10.1002/ana.25333
  6. Published
  7. Published
  8. Published
  9. Published
    Legdeur, N., Heymans, M. W., Comijs, H. C., Huisman, M., Maier, A. B., & Visser, P. J. (2018). Age dependency of risk factors for cognitive decline. BMC Geriatrics, 18, [187]. https://doi.org/10.1186/s12877-018-0876-2
  10. Published
    Konijnenberg, E., Carter, S. F., ten Kate, M., den Braber, A., Tomassen, J., Amadi, C., ... Visser, P. J. (2018). The EMIF-AD PreclinAD study: study design and baseline cohort overview. Alzheimers Research & Therapy, 10, [75]. https://doi.org/10.1186/s13195-018-0406-7
  11. Published
  12. Published
  13. Published
  14. Published
  15. Published
  16. Published
  17. Published
    ten Kate, M., Sudre, C. H., den Braber, A., Konijnenberg, E., Nivard, M. G., Cardoso, M. J., ... Visser, P. J. (2018). White matter hyperintensities and vascular risk factors in monozygotic twins. Neurobiology of Aging, 66, 40-48. https://doi.org/10.1016/j.neurobiolaging.2018.02.002
  18. Published
  19. Published
  20. Published
  21. Published
    Tijms, B. M., Willemse, E. A. J., Zwan, M. D., Mulder, S. D., Visser, P. J., van Berckel, B. N. M., ... Teunissen, C. E. (2018). Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-beta 1-42 Analysis Results. Clinical Chemistry, 64(3), 576-585. https://doi.org/10.1373/clinchem.2017.281055
  22. Published
  23. Published
  24. Published
  25. Published
  26. 2017
  27. Published
  28. Published
  29. Published
  30. Published
  31. Published
  32. Published
    Frisoni, G. B., Boccardi, M., Barkhof, F., Blennow, K., Cappa, S., Chiotis, K., ... Winblad, B. (2017). Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. Lancet Neurology, 16(8), 661-676. https://doi.org/10.1016/S1474-4422(17)30159-X
  33. Published
    Bos, I., Vos, S. J., Froelich, L., Kornhuber, J., Wiltfang, J., Maier, W., ... Alzheimer's Dis Neuroimaging Initi (2017). The frequency and influence of dementia risk factors in prodromal Alzheimer's disease. Neurobiology of Aging, 56, 33-40. https://doi.org/10.1016/j.neurobiolaging.2017.03.034
  34. Published
  35. Published
  36. Published
  37. Published
  38. Published
  39. Published
    Herukka, S-K., Simonsen, A. H., Andreasen, N., Baldeiras, I., Bjerke, M., Blennow, K., ... Waldemar, G. (2017). Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment. Alzheimer's & Dementia, 13(3), 285-295. https://doi.org/10.1016/j.jalz.2016.09.009
  40. Published
    Simonsen, A. H., Herukka, S-K., Andreasen, N., Baldeiras, I., Bjerke, M., Blennow, K., ... Waldemar, G. (2017). Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia. Alzheimer's & Dementia, 13(3), 274-284. https://doi.org/10.1016/j.jalz.2016.09.008
  41. Published
  42. Published
  43. Published
  44. Published
  45. Published
    van Doorn, L. J. C. V. W., Gispert, J. D., Kuiperij, H. B., Claassen, J. A. H. R., Arighi, A., Baldeiras, I., ... Verbeek, M. M. (2017). Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes. Journal of Alzheimer's Disease, 56(2), 543-555. https://doi.org/10.3233/JAD-160668
  46. Published
  47. Published
  48. Published
  49. Published
  50. 2016
  51. Published
  52. Published
  53. Published
    ten Kate, M., Sanz-Arigita, E. J., Tijms, B. M., Wink, A. M., Clerigue, M., Garcia-Sebastian, M., ... Barkhof, F. (2016). Impact of APOE-epsilon 4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults. Neurobiology of Aging, 38, 14-20. https://doi.org/10.1016/j.neurobiolaging.2015.10.018
Previous 1 2 3 Next